NCT07482878

Brief Summary

The goal of this interventional clinical study is to learn if a Tinder fungus-based formulation -specifically a toothpaste and oral supplement powder-works as adjuncts to non-surgical periodontal therapy (NSPT) in patients with periodontitis. The main questions it aims to answer is:

  • Does the Tinder fungus-based formulation as an adjunct to NSPT reduce bleeding on probing more than a commercially available toothpaste as an adjunct to NSPT? Researchers will compare tinder fungus toothpaste and oral powder as an adjunct to NSPT to a commercially available toothpaste as an adjunct to NSPT to see if the Tinder fungus-based formulation works as adjuncts to NSPT in patients with periodontitis. Participants will:
  • Take tinder fungus toothpaste and oral powder or a commercially available toothpaste as an adjunct to NSPT twice daily for 30 consecutive days
  • Visit the clinic at least twice including a visit before and after the intervention
  • Keep a diary documenting their well-being and the number of times they used the toothpastes in the morning and evening.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

July 16, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

March 10, 2026

Last Update Submit

July 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bleeding on probing (BoP in %) change

    Bleeding on probing (BoP in %) changes from baseline (T0) to reevaluation (T1). BOP will be recorded as yes/no for each of 6 sites and reported as the percentage of affected sites per participant.

    changes from baseline (T0; 1 day before intervention starts) to reevaluation (T1; 5 weeks (±1 week) after intervention start)

Study Arms (2)

Tinder fungus-based formulation (toothpaste and oral supplement powder)

EXPERIMENTAL

Tinder fungus toothpaste plus oral supplement powder as adjuncts to non-surgical periodontal therapy (NSPT) in patients with periodontitis

Other: Tinder fungus-based formulation

commercially available toothpaste

ACTIVE COMPARATOR

Commercially available toothpaste as adjuncts to non-surgical periodontal therapy (NSPT) in patients with periodontitis

Other: Commercially available toothpaste

Interventions

Participants will receive Tinder fungus (Fomes fomentarius)-based formulations including a toothpaste plus an oral supplement powder as adjuncts to non-surgical periodontal therapy (NSPT).

Tinder fungus-based formulation (toothpaste and oral supplement powder)

A standard commercially available toothpaste administered as an adjunct to NSPT.

commercially available toothpaste

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with Stage III or IV periodontitis
  • Patients who have not yet initiated periodontal therapy
  • Patients who have at least 20 remaining teeth
  • Patients who are willing to use an electric toothbrush
  • Patients who are willing to use interdental brushes

You may not qualify if:

  • Patients who have previously received treatment for periodontitis
  • Patients who have already undergone or initiated periodontal therapy
  • Patients with a known allergy or intolerance to any component of the toothpaste or the powder
  • Patients who are already using a product that contains tinder fungus (Fomes fomentarius)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dental Clinic of the Sigmund Freud Private University

Vienna, State of Vienna, 1020, Austria

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2026

First Posted

March 19, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

July 16, 2026

Record last verified: 2026-01

Locations